Cited by 47Cardiac Health and Mental HealthTreatment of Major DepressionStress Responses and Cortisol

Link between depression and cardiovascular diseases due to epigenomics and proteomics: Focus on energy metabolism

Kahl, Kai G., Stapel, Britta, Frieling, Helge·2019·Progress in Neuro-Psychopharmacology and Biological Psychiatry

Abstract

Major depression is the most common mental disorder and a leading cause of years lived with disability. In addition to the burden attributed to depressive symptoms and reduced daily life functioning, people with major depression are at increased risk of premature mortality, particularly due to cardiovascular diseases. Several studies point to a bi-directional relation between major depression and cardiovascular diseases, thereby indicating that both diseases may share common pathophysiological pathways. These include lifestyle factors (e.g. physical activity, smoking behavior), dysfunctions of endocrine systems (e.g. hypothalamus-pituitary adrenal axis), and a dysbalance of pro- and anti-inflammatory factors. Furthermore, recent research point to the role of epigenomic and proteomic factors, that are reviewed here with a particular focus on the mitochondrial energy metabolism.

Integrity signals

Registry

Crossref · 10.1016/j.pnpbp.2018.09.004

Cites

231 of 231 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

3 of the 234 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
Kahl, K. G., Stapel, B., & Frieling, H.
Affiliations
Medizinische Hochschule Hannover (DE)
Corresponding author
Kahl, Kai G.
Venue
Progress in Neuro-Psychopharmacology and Biological Psychiatry
Publisher
Elsevier BV
Published
2019-03
Volume
89
Pages
146-157
ISSN
0278-5846 (ISSN-L)
OpenAlex
W2892142660
Cited by
47
References
234
Citations by year
2026: 4 · 2025: 4 · 2024: 5 · 2023: 6 · 2022: 8 · 2021: 7 · 2020: 6 · 2019: 6
FWCI
0.89
Type
journal article
Language
en
Open access
closed
Locations
  • Progress in Neuro-Psychopharmacology and Biological Psychiatry (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Health and Mental Health
  • Health Sciences › Medicine › Pharmacology › Treatment of Major Depression
  • Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
Keywords
major depressive disorder, cardiovascular disease, epigenomics, proteomics, energy metabolism, mitochondrial metabolism, bidirectional relationship, hypothalamic-pituitary-adrenal axis, inflammation, premature mortality, lifestyle factors
MeSH terms
Animals, Cardiovascular Diseases, Major Depressive Disorder, Depressive Disorder, Major, Energy Metabolism, Humans, Proteomics, Epigenesis, Genetic, Epigenomics

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review